TU-572

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTU-572
Drug Alias NamePTPase/CD45 inhibitor (Taisho)protein tyrosine phosphatase/CD45 inhibitor (Taisho)PTP/CD45 inhibitor (Taisho)TU-572
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukocyte common antigen inhibitors
TargetsLeukocyte common antigen
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaisho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A